Liberate-HR LIB003-006

Liberate-HR LIB003-006

The study is designed to evaluate the long-term efficacy and safety of LIB003 in patients with cardiovascular disease or at high risk for cardiovascular disease on stable lipid-lowering therapy who require additional LDL reduction.

Please use this link for further information:

Primary Investigator: Dean Kereiakes

Follow up only

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative